Medical devices called hemostats
and sealants are used to stop bleeding and haemorrhage brought on by wounds and
surgical procedures. Due to a rise in demand supported by increasing surgical
volumes, the market is anticipated to experience profitable growth over the
following seven years. Among the main factors influencing the market are the
rise in the elderly population and the high prevalence of chronic diseases.
Over 45% of Americans, according to statistics from the Centers for Disease
Control and Prevention (CDC), have at least one chronic condition that
necessitates immediate medical attention.
The coronavirus is a major factor
in patient fatalities because it causes thrombotic bleeding and other
complications. The Global
Hemostasis & Tissue Sealing Agents Market expanded as
unbalanced hemostasis in COVID-19 patients in favour of a prothrombotic state
became more significant. The increasing prevalence of hemostatic anomalies in
those who were impacted and their impact on prognosis also had a positive
impact on market growth. Patients with COVID-19 were predicted to experience
critical illness, bleeding, death, and thrombosis by an elevated D-dimer level
at the time of hospital admission. As a result, the market expanded favourably
both before and after COVID-19.
Watch the Video https://lumen5.com/user/poojasalve/hemostasis-tissue-hmvd0/
